Thomas E. Needham Jr.

Insider Reports History

Entity
Individual
Location
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA
Signature
/s/ Joseph Carroll, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas E. Needham Jr.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Renovacor, Inc. Director Stock Option 0 Dec 1, 2022 Direct

Insider Reports Filed by Thomas E. Needham Jr.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCOR Renovacor, Inc. Dec 1, 2022 2 $0 4 Dec 5, 2022 Director
RCOR Renovacor, Inc. May 25, 2022 1 $0 4 May 27, 2022 Director
RCOR Renovacor, Inc. Sep 3, 2021 1 $0 4 Sep 8, 2021 Director
RCOR Renovacor, Inc. Sep 2, 2021 0 $0 3 Sep 8, 2021 Director